Hypocholesterolemia

Ogden CL, Flegal KM, Carroll MD, Johnson CL. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 2002; 288: 1728-32.

Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295: 1549-55.

McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991; 337: 382-6.

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel. Arch Intern Med 1988; 148: 36-69.

Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 1995; 333: 1301-7.

Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF, Waters D, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 2001; 285: 1711-8.

WHO cooperative trial on primary prevention of ischaemic heart disease with clofibrate to lower serum cholesterol: final mortality follow-up. Report of the Committee of Principal Investigators”. Lancet 1984; 2: 600–4.

Mathew BC, Daniel RS. Cholesterol: A century of research and debate. Libyan J Med 2008; AOP: 080422.

Available from http://www.experiencefestival.com/ cholesterol_-_history_of_the_name

D’Arienzo A, Manguso F, Scaglione G, Vicinanza G, Bennato R, Mazzacca G. Prognostic value of progressive decrease in serum cholesterol in predicting survival in Child-Pugh C viral cirrhosis. Scand J Gastroenterol. 1998; 33:1213-8.

Oster P, Muchowski H, Heuck CC, Schlierf G. The prognostic significance of hypocholesterolemia in hospitalized patients. Klin Wochenschr 1981; 59: 857-60.

Glueck CJ, Kelley W, Gupta A, Fontaine RN, Wang P, Gartside PS. Prospective 10-year evaluation of hypobetalipoproteinemia in a cohort of 772 firefighters and crosssectional evaluation of hypocholesterolemia in 1,479 men in the National Health and Nutrition Examination Survey I. Metabolism 1997; 46: 625-33.

Elmehdawi RR. Hypolipidemis: A word of caution. Liyan J Med 2008; 3: AOP: 071221.

Shalev H, Kapelushnik J, Moser A, Knobler H, Tamary H. Hypocholesterolemia in chronic anemias with increased erythropoietic activity. Am J Hematol 2007; 82: 199-202.

Shores J, Peterson J, VanderJagt D, Glew RH. Reduced cholesterol levels in African-American adults with sickle cell disease. J Natl Med Assoc 2003; 95: 813-7.

Hartman C, Tamary H, Tamir A, Shabad E, Levine C, Koren A, et al. Hypocholesterolemia in children and adolescents with beta-thalassemia intermedia. J Pediatr 2002; 141: 543-7.

Yokoyama M, Suto Y, Sato H, Arai K, Waga S, Kitazawa J, et al. Low serum lipids suggest severe bone marrow failure in children with aplastic anemia. Pediatr Int 2000; 42: 613-9.

Bjerve KS, Evensen SA, Stray-Pedersen S, Skrede S. On the pathogenesis of acquired hypo-beta-lipoproteinemia. A case associated with sideroblastic anemia. Acta Med Scand 1982; 211: 313-8.

Wilson RF, Barletta JF, Tyburski JG . Hypocholesterolemia in sepsis and critically ill or injured patients. Crit Care 2003; 7: 413-4.

L’vesque H, Gancel A, Pertuet S, Czernichow P, Courtois H. Hypocholesterolemia: prevalence, diagnostic and prognostic value. Study in a department of internal medicine. Presse Med 1991; 20: 1935-8.

Shah SS, Desai HG. Apolipoprotein deficiency in chronic liver disease. J Assoc Physicians India 2001; 49: 274-8.

Segal AZ, Chiu RI, Eaggleston-Sexton PM, Beiser A, Greenberg SM. Low cholesterol as a risk factor for primary intracerebral hemorrhage: a case-control study. Neuroepidemiology 1999; 18: 185-93.

Iribarren C, Jacobs DR, Sadler M, Claxton AJ, Sidney S. Low total serum cholesterol and intracerebral hemorrhagic stroke: is the association confined to elderly men? The Kaiser Permanente Medical Care Program. Stroke 1996; 27: 1993-8.

Shinkawa A, Ueda K, Hasuo Y, Kiyohara Y, Fujishima M. Seasonal variation in stroke incidence in Hisayama, Japan. Stroke 1990; 21: 1262-7.

Marik PE. Dyslipidemia in the critically ill. Crit Care Clin 2006; 22: 151-9.

Muldoon MF, Marsland A, Flory JD, Rabin BS, Whiteside TL, Manuck SB. Immune system differences in men with hypo-or hypercholesterolemia. Clin Immunol Immunopathol 1997; 84: 145-9.

Harris HW, Grunfeld C, Feingold KR, Read TE, Kane JP, Jones AL, Eichbaum EB, Bland GF, Rapp JH. Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. J Clin Invest 1993; 91: 1028-34.

Leardi S, Altilia F, Delmonaco S, Cianca G, Pietroletti R, Simi M. Blood levels of cholesterol and postoperative septic complications. Ann Ital Chir 2000; 71: 233-7.

Richardson JP, Hricz L. Risk factors for the development of bacteremia in nursing home patients. Arch Fam Med 1995; 4: 785-9.

Crook MA, Velauthar U, Moran L, Griffiths W. Hypocholesterolemia in a hospital population. Ann Clin Biochem 1999; 36: 613-6.

Hsiao C, Miqdadi J. Hypolipidemia Impacts Mortality in Patients with HIV and Hepatitis C Co-infection. Antimicrob Agents Chemother 2002; 46: 27-30.

Tomiki Y, Suda S, Tanaka M, Okuzawa A, Matsuda M, Ishibiki Y, et al. Reduced low-density-lipoprotein cholesterol causing low serum cholesterol levels in gastrointestinal cancer: a case control study. J Exp Clin Cancer Res. 2004; 23: 233-40.

Perez-Guzman C, Vargas MH, Quinonez F, Bazavilvazo N, Aguilar A. A cholesterol-rich diet accelerates bacteriologic sterilization in pulmonary tuberculosis. Chest 2005; 127: 643-51.

Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial. Lancet 2002; 360: 1623-30.

LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005; 352: 1425-35. Epub 2005 Mar 8.

Newman TB, Hulley SB. Carcinogenicity of lipid-lowering drugs. JAMA 1996; 275: 55-60.

Strandberg TE, Pyorala K, Cook TJ, Wilhelmsen L, Faergeman O, Thorgeirsson G, et al. Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S). Lancet 2004; 364: 771-7.